Abstract
The transforming growth factor-β (TGF-β) signalling pathway plays a critical role in carcinogenesis. It has a biphasic action by initially suppressing tumorigenesis but promoting tumour progression in the later stages of disease. Consequently, the functional outcome of TGF-β signalling is strongly context-dependent and is influenced by various factors including cell, tissue and cancer type. Disruption of this pathway can be caused by various means, including genetic and environmental factors. A number of human viruses have been shown to modulate TGF-β signalling during tumorigenesis. In this review, we describe how this pathway is perturbed in Epstein-Barr virus (EBV)-associated cancers and how EBV interferes with TGF-β signal transduction. The role of TGF-β in regulating the EBV life cycle in tumour cells is also discussed.
Original language | English |
---|---|
Article number | 247 |
Number of pages | 23 |
Journal | Cancers |
Volume | 10 |
Issue number | 8 |
DOIs | |
Publication status | Published - 27 Jul 2018 |
Keywords
- TGF-β signalling
- Epstein-Barr virus
- nasopharyngeal carcinoma
- gastric cancer
- B-cell lymphoma